Clinical trial
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant…
NCT00101283 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00101283 |
|---|---|
| Title | Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma |
| Official title | Pemetrexed Plus Gemcitabine Or Carboplatin In Patients With Advanced Malignant Mesothelioma: A Randomized Phase II Trial |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH North Central Cancer Treatment Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mesothelioma |
| Intervention type | Drug |
| Interventions | pemetrexed disodium, gemcitabine hydrochloride, carboplatin |
| Enrollment | 32 |
| Start date | Feb 23, 2006 |
| Primary completion | Sep 1, 2009 |
| Completion | May 1, 2011 |
| First posted | Jan 10, 2005 |
| Last update posted | Jul 3, 2023 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: